My Profile
Edit Profile
My Follows
My Wires
My Drafts
Analytics
Email Preferences
Sign Out
home
most popular
Latest
Buy Hold Sell
Listed Series
Series
Alternatives in Focus
Buy Hold Sell
Expert Insights
Fund in Focus
Income Series
Listed Series
Livewire Live
Meet The Adviser
Meet The Investor
Outlook Series
Rapid Fire
Reporting Season
Success and More Interesting Stuff
The Pitch
The Rules of Investing
Undiscovered Funds
Views from the Top
Categories
Asset Allocation
Commodities
Daily Report
Education
Equities
Fixed Income
Funds
Investment Theme
Macro
Private Assets
Property
Weekend Report
Contributors
Find Funds
Newsletter
About Livewire
Advertising
Careers
Contact Us
Write a Wire
Notifications
Loading...
Write a wire
Account
My profile
My follows
My wires
My drafts
Analytics
Email preferences
Company
About Livewire
Advertising
Contact us
Sign out
Sign In
Join Free
Latest
Buy Hold Sell
Listed Series
Series
Buy Hold Sell
Fund in Focus
Livewire Live
Meet The Investor
Rapid Fire
Reporting Season
Success and More Interesting Stuff
The Pitch
The Rules of Investing
Views from the Top
Categories
Asset Allocation
Commodities
Daily Report
Education
Equities
Fixed Income
Funds
Investment Theme
Macro
Private Assets
Property
Weekend Report
Find funds
Newsletter
NDF Research
Latest news and analysis on NDF Research
September 07, 2016 19:16
Botanix Pharmaceuticals (ASX: BOT) - Management that have done it before
Stuart Roberts
Pitt Street Research and NDF Research
September 07, 2016 19:16
September 06, 2016 06:41
Mesoblast (ASX: MSB) - Why I expect Team Silviu can make a strong comeback
Stuart Roberts
Pitt Street Research and NDF Research
September 06, 2016 06:41
September 05, 2016 11:14
Cynata (ASX: CYP) - Australian stem-cell know-how gets picked up in Japan
Stuart Roberts
Pitt Street Research and NDF Research
September 05, 2016 11:14
Advertisement
September 05, 2016 10:34
Sirtex (ASX: SRX) - A therapy going mainstream
Stuart Roberts
Pitt Street Research and NDF Research
September 05, 2016 10:34
September 02, 2016 07:20
AirXpanders (ASX: AXP) - Big step forward for patients, potentially big money for investors
Stuart Roberts
Pitt Street Research and NDF Research
September 02, 2016 07:20
September 01, 2016 07:22
Starpharma (ASX:SPL) - It's big business putting new life into old drugs
Stuart Roberts
Pitt Street Research and NDF Research
September 01, 2016 07:22
August 26, 2016 16:10
The Coming Boom in Life Sciences in Australia
Stuart Roberts
Pitt Street Research and NDF Research
August 26, 2016 16:10
41-47 of 47
1
2
3
most
popular
Equities
2 ASX mining stocks that could double (or more) in a year
Tom Stelzer,
Livewire Markets
Equities
Why boring stocks can be good investments – and one I like
Patrick Poke,
A Rich Life
Equities
This recently triggered market signal has never failed to predict gains
Andrew Mitchell,
Ophir Asset Management
Private Assets
Metrics Real Estate Income Fund: broadening access to a wider range of
investors
Chris Conway,
Livewire Markets
view all
Advertisement
